Determination of synthetic cathinone "α-PVP" and its metabolite in urine using solid phase extraction and gas chromatography-mass spectrometry.
The presence of α-PVP and its metabolites in urine is the evidence of the administration of α-PVP. A toxicological challenge is that the metabolites of α-PVP exhibit amphoteric properties, which make them unsuitable for detection using GC-MS. Herein, proper derivatization and sample extraction were essential to improve the sensitivity for GC-MS analysis. An auto-SPE method has been developed and optimized. The derivatization efficiency was tested by using longer reaction time and the addition of polar pyridine into the mixture of BSTFA with 1% TMCS. Method validation, including linearity, limit of detection, precision, accuracy, and recovery, was evaluated using an automatic SPE and GC-MS. The results suggested that adding pyridine to BSTFA (1:1, v/v) significantly improved the derivatization efficiency and precision. After optimization, the linear range was from 25 ng mL-1 to 1000 ng mL-1 with R2 > 0.9950. The LOD was 5 ng mL-1 for α-PVP and 25 ng mL-1 for OH-α-PVP. The recovery of SPE was over 88%. The inter-day and intra-day precisions were < 15%. A forensic sample has been found containing α-PVP (67.3 ng mL-1 ) and OH-α-PVP (560.2 ng mL-1 ). This study was the first to validate an auto-SPE-GC-MS method for the quantification and qualification of α-PVP and OH-α-PVP in urine. We have successfully improved the derivatization efficiency and developed a sensitive and semi-automatic approach. This approach is desirable for the detection of synthetic cathinone at trace levels in biological samples.